Results 21 to 30 of about 5,408,332 (199)

CT and MRI Findings of Hepatic Involvement in Rendu-Osler-Weber Disease [PDF]

Case Reports in Radiology, 2012
Rendu-Osler-Weber disease is a rare autosomal dominant disorder. Hepatic involvement manifests itself as vascular, parenchymal, and biliary lesions with characteristic telangiectasias and vascular shunts. In a 37-year-old female patient, dynamic contrast-
Mehmet Bilgin, Seyma Yildiz, Huseyin Toprak, Issam Cheikh Ahmad, Ercan Kocakoc   +4 more
doaj   +2 more sources

Final observation of an extremely severe case of Osler-Weber-Rendu disease in teaching at the pregraduate and postgraduate stages of education and the use of current English-language Internet applications for doctors and patients

Медицина неотложных состояний, 2023
Hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu syndrome, Osler-Weber-Rendu disease, etc) is diagnosed clinically according to the so called Curacao criteria, if at least three of four of them are present: recurrent spontaneous epistaxis ...
V.M. Rudichenko, N.V. Snigir, V.О. Кrivets   +2 more
doaj   +1 more source

Spontaneous haemothorax in Osler-Weber-Rendu disease [PDF]

Postgraduate Medical Journal, 1983
Summary A case of hereditary haemorrhagic telangiectasia (Osler-Weber-Rendu disease) is described who presented with severe, central chest pain mimicking acute myocardial infarction, a presentation which has not been described before. He was found to have developed spontaneous haemothorax which is a very rare complication of this disease.
A M, Karnik, A, Sughayer, F F, Fenech
openaire   +2 more sources

Rheumatoid arthritis associated with Rendu — Osler — Weber disease: Second description [PDF]

, 2021
The article presents second ever published description of rheumatoid arthritis case co-morbid with Rendu — Osler — Weber disease (hereditary hemorrhagic teleangiectasia) in a 63-yearsold female patient.
de Carvalho, Jozélio Freire, Maia Rodrigues, Carlos Ewerton, Churilov, Leonid P., de Freitas Zerbini, Cristiano Augusto   +3 more
core   +1 more source

Left extended hepatectomy with biliary resection and reconstruction for hilar cholangiocarcinoma in patient with Osler-Rendu-Weber disease: a case report and review of literature. [PDF]

Updates Surg
: Osler-Rendu-Weber syndrome is a genetic disease that involves organs, liver included, characterized by alterations in the vessel walls, making them more vulnerable to spontaneous rupture and bleeding indeed.
Marchese A, Conci S, Pecori S, Castelli C, Contro A, Mansueto G, Scarpa A, Ruzzenente A.   +7 more
europepmc   +2 more sources

Rotational angiography and the contribution of roadmapping to the occlusion of arteriovenous malformations. How would I approach it?

REC: Interventional Cardiology (English Ed.), 2022
HOW WOULD I APPROACH IT? Authors present an interesting case of a 10-year-old with a familial history of Rendu-Osler-Weber disease. The patient shows signs of cyanosis, polyglobulia, and baseline oxygen saturation levels of 85% due to a large and ...
Roberto Blanco Mata
doaj   +1 more source

Ischemic cholangitis during Osler-Weber-Rendu disease: a case report

Egyptian Liver Journal, 2022
Background Osler-Weber-Rendu disease (OWRD) is a rare autosomal dominant genetic disease that causes skin and mucosal telangiectasias and visceral arteriovenous malformations.
Oussama Kharmach, Mohamed Borahma, Nawal Lagdali, Imane Benelbarhdadi, Fatima-Zohra Ajana   +4 more
doaj   +1 more source

Case of Osler-Weber-Rendu Syndrome Complicated with Nasal Septum Perforation

Central Asian Journal of Medical Sciences, 2020
Objectives: Hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu disease) is a rare autosomal dominant disorder characterized by multiple mucocutaneous telangiectasias and visceral arteriovenous malformations.
Odgerel Tsogbadrakh, Injinaash Ogoosambuu, Layala Jukhai, Munkhhbaatar Davaasumberel, Khatanbaatar Alexandr   +4 more
doaj   +1 more source

Efficacy and safety of intravenous bevacizumab on severe bleeding associated with hemorrhagic hereditary telangiectasia: A national, randomized multicenter trial

Journal of Internal Medicine, Volume 294, Issue 6, Page 761-774, December 2023., 2023
Abstract Background Bevacizumab—a humanized monoclonal antibody—has been widely used to treat patients with hereditary hemorrhagic telangiectasia (HHT), but no randomized trial has yet been conducted. Methods This study is a double‐blind multicenter randomized phase 2 trial with a 1:1 active‐treatment‐to‐placebo ratio. We included patients over the age
Sophie Dupuis‐Girod, Sophie Rivière, Christian Lavigne, Anne‐Emmanuelle Fargeton, Brigitte Gilbert‐Dussardier, Vincent Grobost, Vanessa Leguy‐Seguin, Hélène Maillard, Shirine Mohamed, Evelyne Decullier, Adeline Roux, Lorraine Bernard, Jean‐Christophe Saurin, Nicolas Saroul, Frédéric Faure, Cesar Cartier, Romain Altwegg, Laurent Laccourreye, Frédéric Oberti, Marjolaine Beaudoin, Carole Dhelens, Céline Desvignes, Nicolas Azzopardi, Gilles Paintaud, Ruben Hermann, Thierry Chinet   +25 more
wiley   +1 more source

OSLER – WEBER – RENDU SYNDROME: A RARE CASE OF UPPER GASTROINTESTINAL BLEEDING [PDF]

, 2022
BACKGROUND: Osler-Weber-Rendu syndrome (Hereditary hemorrhagic telengiectasia) cases present with recurrent epistaxis, gastrointestinal bleeding (hematemesis, melena), and arteriovenous malformations involving almost all organs of body.
Muhammad Ahmed Khan, Farrukh Sher, Sumera Akram   +2 more
core   +1 more source